GHRP-6 vs Ipamorelin — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
GHRP-6 is the original growth hormone releasing peptide, discovered by Cyril Bowers in the 1970s through systematic study of enkephalin analogs. It was the first molecule to reveal the existence of the ghrelin receptor pathway, predating the discovery of ghrelin itself....
Calculate GHRP-6 dose →Ipamorelin is a synthetic 5-amino acid growth hormone releasing peptide (GHRP) that selectively stimulates pituitary GH secretion without raising cortisol, prolactin, or appetite hormones. Acts on ghrelin receptors (GHSR-1a) for clean pulsatile GH release. Phase I/II research sta...
Calculate Ipamorelin dose →| Parameter | GHRP-6 | Ipamorelin |
|---|---|---|
| Category | Growth Hormone | Growth Hormone |
| Research | Extensively Studied | Extensively Studied |
| Half-Life | ~15–60 min | ~2 hours |
| Typical Dose | 100–300 µg | 100–300 µg |
| Frequency | 2–3× daily | 1–3× daily |
| Route | Subcutaneous | Subcutaneous |
| FDA Status | Not Approved | Not Approved |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.